Anna Ermacora

824 citations
27 papers · 595 · h-index 13

Impact in

  • Hematology top 5%
    • Acute Myeloid Leukemia Research
  • Oncology top 10%
    • Drug Transport and Resistance Mechanisms

Papers in

    • Drug Transport and Resistance Mechanisms 11
    • Chronic Lymphocytic Leukemia Research 5

Anna Ermacora

26 papers receiving 569 citations

Peers

Anna Ermacora
Comparison fields: 5 of 52
  • Hematology 188
  • Oncology 254
  • Genetics 76
  • Hepatology 50
  • Public Health, Environmental and Occupational Health 89
Replace Entezam Sahovic with:
Entezam Sahovic United States
Alaa Elhaddad Egypt
P Hentschke Sweden
Ted Gooley United States
Peter Waldron United States
M. Patrick Stagg United States
Nan Young Lee South Korea
Errol L. Berman United States
Kyu Bo Lee South Korea
Kyoo Hyung Lee South Korea
Anna Ermacora relative to Entezam Sahovic United States Entezam Sahovic's profile →
Citations per field
00.5×1.5×2.3×
Entezam Sahovic · 1×
Citations per year

Countries citing papers authored by Anna Ermacora

Since Specialization
Citations

This map shows the geographic impact of Anna Ermacora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Ermacora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Ermacora more than expected).

Fields of papers citing papers by Anna Ermacora

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Ermacora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Ermacora. The network helps show where Anna Ermacora may publish in the future.

Co-authors

The 25 scholars most cited alongside Anna Ermacora, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna Ermacora Line = papers co-authored together Anna Ermacora links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1999100
2 199977
3 199763
4 199944
5
Rituximab for the treatment of type II mixed cryoglobulinemia.
199942
6 200041
7 200233
8
P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemias.
199831
9 201826
10 200024
11
Effect of fludarabine and arabinosylcytosine on multidrug resistant cells.
199722
12 199818
13 199917
14 201611
15 201210
16
Lamivudine for the prevention of hepatitis B virus reactivation during autologous stem cell transplantation. A case report.
20008
17
Overcoming PGP-related multidrug resistance. The cyclosporine derivative SDZ PSC 833 can abolish the resistance to methoxy-morpholynil-doxorubicin.
19966
18 20215
19 20204
20 20204

About Anna Ermacora

Anna Ermacora is a scholar working on Oncology, Genetics, Hepatology, Public Health, Environmental and Occupational Health and Molecular Biology, having authored 27 papers that have together received 595 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (11 papers), Hepatitis C virus research (6 papers), Acute Lymphoblastic Leukemia research (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Hepatitis B Virus Studies (3 papers), Systemic Lupus Erythematosus Research (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (188 citations), Oncology (254 citations), Genetics (76 citations), Hepatology (50 citations) and Public Health, Environmental and Occupational Health (89 citations). Anna Ermacora has collaborated with scholars based in Italy, Ukraine and Philippines. Frequent co-authors include Michele Baccarani, Mariagrazia Michieli, Daniela Damiani, Paola Masolini, Angela Michelutti, Domenico Russo, Donatella Raspadori, Renato Fanin, R.J. Scheper and Giuseppe Visani. Their work appears in journals such as British Journal of Haematology, Hematological Oncology, Blood, Leukemia and European Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact